Massivemarkets

ANIP

ANI Pharmaceuticals, Inc.

Nasdaq · usd

$67.41-2.21 (-3.17%)
At close · 15-minute delayed
$67.75+0.34 (+0.50%)
As of 7:34:24 PM EST on Nov 6, 2026 · After hours

ANI Pharmaceuticals, Inc. (ANIP) trades at $67.41 (-3.17%) as of 7:34:24 PM EST on Nov 6, 2026, -6.35% over the past month. Market cap is $1.53B, with 10.1 days to cover in short interest.

Stock performance

How ANI Pharmaceuticals, Inc. (ANIP) stock has performed from one day to one year, with its 52-week range.

-3.35%
-$2.34 over 1D
$67.43$68.42$69.40$70.398:40 AM11:10 AM12:50 PM2:25 PM8:00 PM$67.41
1D
-3.17%
1W
-6.38%
1M
-6.35%
YTD
-14.61%
1Y
-24.20%
52-wk range
$67.14 – $90.87

Key statistics

Today's trading snapshot for ANIP: day range, open, previous close, volume and market cap.

Day range
$67.14 – $70.95
Open
$69.05
Prev close
$69.62
Volume
578.18K
Market cap
$1.53B
Shares out
22.96M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for ANI Pharmaceuticals, Inc.: P/E, P/S, P/B, ROE and more.

P/E
15.38
P/S
1.57
P/B
2.57
P/FCF
8.86
ROE
16.7%
ROA
6.7%
Debt/Equity
1.02
Div yield
0.02%

As of Nov 6, 2026

8-K filings

Material corporate events ANI Pharmaceuticals, Inc. has disclosed to the SEC on Form 8-K.

  • Tender offerNov 5, 2026

    In the Offer, the Company is offering SEK 11.25 in cash for each share of Egetis, SEK 65,750,817 in cash for the EUR 3 million principal amount of the Convertible and SEK 6.99 in cash per Warrant (representing a total value of approximately SEK 5.6 billion or approximately $559.9 million...).

  • Investor presentationNov 5, 2026

    On November 5, 2026, the Company provided a presentation in connection with a conference call and webcast that will be held on November 5, 2026 with analysts and investors regarding its third quarter 2026 results and the proposed Egetis Therapeutics acquisition.

  • Director appointmentAug 24, 2026

    On August 19, 2026, the Board of Directors (the "Board") of ANI Pharmaceuticals, Inc. (the "Company") appointed Henry Gosebruch to serve on the Board as a director with a term expiring at the Company's 2027 annual meeting of stockholders. Mr. Gosebruch, 53, has served as Chief Executive Officer and a member of the board of directors of Lakefront Biotherapeutics NV... Prior to Lakefront, Mr. Gosebruch served as President and Chief Executive Officer of Neumora Therapeutics, Inc.

  • Investor presentationAug 7, 2026

    On August 7, 2026, the Company published an updated investor presentation to the investor relations section of its website. The Company may use the updated investor presentation in various meetings with investors and analysts from time to time.

  • Annual meeting resultsMay 21, 2026

    At the Annual Meeting, (i) each of the seven (7) director nominees were elected, (ii) the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified, (iii) the compensation of the Company's named executive officers was approved on an advisory basis, (iv) the stockholders voted, on an advisory basis, that future advisory votes to approve the compensation of the Company's named executive officers be held every one year, and (v) the Amended 2022 Stock Plan was approved.

Dividend history and stock splits

ANI Pharmaceuticals, Inc.'s recent dividend payments and stock splits.

Dividends

No recent dividends.

Splits

  • 1-for-6Jun 4, 2012

ANIP short interest

How heavily ANIP is shorted: shares short, days to cover and average daily volume.

Days to cover
10.1
Short interest
3.47M
Avg volume
343.76K

As of · reported to FINRA twice monthly.

ANIP news

The latest news and headlines about ANI Pharmaceuticals, Inc. (ANIP).

Frequently asked questions

What is the ANI Pharmaceuticals, Inc. (ANIP) stock price today?

ANI Pharmaceuticals, Inc. (ANIP) is trading at $67.41 (-3.17% on the day) as of 7:34:24 PM EST on Nov 6, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology,…

What is the short interest in ANIP?

As of Oct 15, 2026, ANIP has 3.47M shares short and 10.1 days to cover.

What exchange is ANIP listed on?

ANI Pharmaceuticals, Inc. (ANIP) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of ANIP with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ANIP analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.